Evaluations of Ultra-Lyte™

Ultra-Lyte™ passed all required AOAC Use Dilution Tests as part of its EPA registration as a biocide.

In additional AOAC Use Dilution Tests performed by an EPA approved laboratory, following Data requirements of U.S. EPA 40 CFR Part 158, Ultra-Lyte™ showed efficacy against the following pathogens:

ATCC 33592: Methicillin Resistant Staphylococcus aureus - MRSA

ATCC 35158: Escherichia coli O157:H7

ATCC 19111: Listeria monocytogenes

Virus efficacy of a disinfectant on inanimate environmental surfaces

Virus: lnfluenza A (H1N1) virus

Ultra-Lyte™ has also passed testing for Health Canada approval as a medical hospital disinfectant.

Using the same EPA approved laboratory, a 600ppm version of Ultra-Lyte™ with an active ingredient of 94.5% hypochlorous acid (HOCL) was able to destroy Staphylococcus aureus and Pseudomonas aeruginosa in only three minutes.

Our technology is accepted for use by the United States Department of Homeland Security for biological incident response.

Clarentis LLC is committed to continuing its R&D to manufacture liquids with a longer shelf life.